Highlights
NASDAQ: RGLS       Regulus Therapeutics
Last Price Today's Change   Day's Range   Trading Volume
1.21   -0.025 (2.02%)  1.20 - 1.28  217,500

Overview

 
Avg Volume (4 weeks):435,138
4 Weeks Range:0.618 - 1.74
4 Weeks Price Volatility (%):
52.76%
52 Weeks Range:0.50 - 1.74
52 Weeks Price Volatility (%):
57.26%
Average Price Target: 27.00
Price Target Upside/Downside: +25.79

Headlines



No recent Headlines for this stock.


Business Background

Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. MicroRNA is a noncoding ribonucleic acid that regulates most genes in the genome. The company partnered with Sanofi to create a compound targeting orphan diseases and with AstraZeneca to cure Type 2 Diabetes/prediabetes.

  Be the first to like this.
 
actvtrader I like the 50.00 price target for yahoo!
22/10/2014 3:48 PM


 

3414  4674  636  186 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 NIO 4.67+0.30 
 TTNP 0.334+0.084 
 SPY 331.95+1.03 
 SNCA 1.60+0.35 
 EEM 46.23+0.26 
 AVP 5.60-0.05 
 AMD 50.93+1.16 
 CHK 0.661-0.029 
 BAC 34.71-0.01 
 GE 11.81-0.03 
Partners & Brokers